{
    "Buyer": {
        "Buyer": "Johnson & Johnson (NYSE:JNJ)",
        "URL": null
    },
    "Target": {
        "Target": "Shockwave Medical, Inc.",
        "URL": null
    },
    "Date announced": {
        "Date announced": "04/05/2024",
        "URL": "https://www.biopharmadive.com/news/jnj-shockwave-medical-acquisition/712424/"
    },
    "Date closed": {
        "Date closed": "05/31/2024",
        "Full URL": "https://www.massdevice.com/johnson-johnson-completes-shockwave-medical-acquisition/"
    },
    "Industry of Target (1 or 2 words maximum)": {
        "Industry of Target": "Medical Devices",
        "Full URL": "https://www.massdevice.com/johnson-johnson-completes-shockwave-medical-acquisition/"
    },
    "Acquired percentage of the business as number": {
        "Acquired percentage of the business": 100,
        "URL": "https://www.massdevice.com/johnson-johnson-completes-shockwave-medical-acquisition/"
    },
    "Private or public deal? (return 1 word - either public or private)": {
        "deal_type": "public",
        "url": "https://www.massdevice.com/johnson-johnson-completes-shockwave-medical-acquisition/"
    },
    "Deal size, mln $": {
        "Deal size, mln $": 13100.0,
        "full URL": "https://www.massdevice.com/johnson-johnson-completes-shockwave-medical-acquisition/"
    },
    "Premium (one-day prior the announcement)": {
        "Premium (one-day prior the announcement)": null,
        "Full URL": "https://www.marketscreener.com/quote/stock/SHOCKWAVE-MEDICAL-55399621/news/Johnson-Johnson-completed-the-acquisition-of-Shockwave-Medical-Inc-from-a-group-of-sellers-46876056/"
    },
    "Implied equity value (capitalization of target company - price of one share multiplied by number of target\u2019s shares on the moment of deal announcement), mln $": {
        "Implied equity value (capitalization of target company)": 13.1,
        "URL": "https://www.massdevice.com/johnson-johnson-completes-shockwave-medical-acquisition/"
    },
    "Implied Net Debt (preferrably taken from last balance sheet prior to the deal, calculated as target company's total debt minus cash), mln $": {
        "Implied Net Debt": null,
        "URL": "https://www.medtechdive.com/news/jnj-shockwave-medical-acquisition/712374/"
    },
    "Form of consideration (return either all-cash, all-stock, all-debt, mixture (in this case return )  ": {
        "Form of consideration": "all-cash",
        "URL": "https://www.massdevice.com/johnson-johnson-completes-shockwave-medical-acquisition/"
    },
    "Short deal description (maximum 125 symbols)": {
        "Short deal description": "Johnson & Johnson acquired Shockwave Medical for $13.1 billion, expanding its cardiovascular portfolio with intravascular lithotripsy (IVL) technology to treat calcified arterial plaque in coronary and peripheral artery diseases.",
        "Full URL": "https://www.massdevice.com/johnson-johnson-completes-shockwave-medical-acquisition/"
    },
    "Revenue for the full year of the announcement date (if no information, take the revenue for the year which preceeded the announcement date), mln $": {
        "Revenue": null,
        "URL": "https://www.medtechdive.com/news/jnj-shockwave-medical-acquisition/712374/"
    },
    "EBITDA (calculated as operating profit plus depreciation) for the full year of the announcement date (if no information, take the revenue for the year which preceeded the announcement date),mln $": {
        "EBITDA": null,
        "URL": "https://www.medtechdive.com/news/jnj-shockwave-medical-acquisition/712374/"
    },
    "Short Business description of target company (maximum 125 symbols)": {
        "short_business_description": "Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases.",
        "full_URL": "https://stockanalysis.com/stocks/swav/company/"
    },
    "Advisor to Target (seller) company (if several advisors were on the deal, return all known)": {
        "Advisor to Target": "null",
        "Full URL": "https://www.massdevice.com/johnson-johnson-completes-shockwave-medical-acquisition/"
    },
    "Advisor to Buyer (acquirer) (if several advisors were on the deal, return all known)": {
        "Advisor to Buyer": "J.P. Morgan Securities LLC",
        "URL": "https://www.marketscreener.com/quote/stock/SHOCKWAVE-MEDICAL-55399621/news/Johnson-Johnson-completed-the-acquisition-of-Shockwave-Medical-Inc-from-a-group-of-sellers-46876056/"
    },
    "Accretive or Dilutive deal": {
        "deal_type": "accretive",
        "url": "https://www.massdevice.com/johnson-johnson-completes-shockwave-medical-acquisition/"
    },
    "Main rationale (why the acquirer purchased the target? - (maximum 125 symbols))": {
        "Main rationale": "To expand Johnson & Johnson's cardiovascular portfolio into high-growth segments of coronary artery disease (CAD) and peripheral artery disease (PAD) using Shockwave Medical's intravascular lithotripsy (IVL) technology.",
        "URL": "https://www.massdevice.com/johnson-johnson-completes-shockwave-medical-acquisition/"
    }
}